<?xml version="1.0" encoding="UTF-8"?>
<p>Overall, 
 <italic>in vitro</italic> models have proved to be a useful tool to study MBF, with examples that study virus molecular mechanisms (Correa et al., 
 <xref rid="B50" ref-type="bibr">2015</xref>; Londono-Renteria et al., 
 <xref rid="B126" ref-type="bibr">2017</xref>; Rattanamahaphoom et al., 
 <xref rid="B172" ref-type="bibr">2017</xref>), their implication in the inflammatory response (Lim et al., 
 <xref rid="B124" ref-type="bibr">2014</xref>; Duran et al., 
 <xref rid="B72" ref-type="bibr">2016</xref>), drug screening (Stolp et al., 
 <xref rid="B198" ref-type="bibr">2015</xref>; Wang L. F. et al., 
 <xref rid="B223" ref-type="bibr">2015</xref>; Sayce et al., 
 <xref rid="B183" ref-type="bibr">2016</xref>), or vaccine development (Nantachit et al., 
 <xref rid="B146" ref-type="bibr">2016</xref>, 
 <xref rid="B147" ref-type="bibr">2017</xref>; Kam et al., 
 <xref rid="B109" ref-type="bibr">2017</xref>). Thus, human cell-derived 
 <italic>in vitro</italic> models could present a solution to modeling MBF infection and neuropathogenesis.
</p>
